101.
Risk factors for hospitalisation and poor outcome with pandemic A/H1N1 influenza: United Kingdom first wave (May–September 2009)
by Nguyen-Van-Tam, J S
Thorax, 2010, Vol.65 (7), p.645-651
102.
Hepatitis E
by Kamar, Nassim, Prof
The Lancet (British edition), 2012, Vol.379 (9835), p.2477-2488
103.
Human respiratory syncytial virus viroporin SH: a viral recognition pathway used by the host to signal inflammasome activation
by Triantafilou, Kathy
Thorax, 2013, Vol.68 (1), p.66-75
104.
Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial
by Zaman, K, PhD
The Lancet (British edition), 2010, Vol.376 (9741), p.615-623
105.
Dengue and dengue vectors in the WHO European region: past, present, and scenarios for the future
by Schaffner, Francis, PhD
The Lancet infectious diseases, 2014, Vol.14 (12), p.1271-1280
106.
Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirs
by Katlama, Christine, Prof
The Lancet (British edition), 2013, Vol.381 (9883), p.2109-2117
107.
Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study
by Marcellin, Patrick, Prof
The Lancet (British edition), 2013, Vol.381 (9865), p.468-475
108.
Effect of nitazoxanide in adults and adolescents with acute uncomplicated influenza: a double-blind, randomised, placebo-controlled, phase 2b/3 trial
by Haffizulla, Jason, MD
The Lancet infectious diseases, 2014, Vol.14 (7), p.609-618
109.
Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review
by Warren-Gash, Charlotte, Dr
The Lancet infectious diseases, 2009, Vol.9 (10), p.601-610
110.
Maternal Infection Requiring Hospitalization During Pregnancy and Autism Spectrum Disorders
by Atladóttir, Hjördis Ó
Journal of autism and developmental disorders, 2010, Vol.40 (12), p.1423-1430
111.
Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013
by Guinovart, Caterina, PhD
The Lancet (British edition), 2014, Vol.384 (9947), p.1005-1070
112.
Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis
by ATTIA, Suzanna
AIDS (London), 2009, Vol.23 (11), p.1397-1404
113.
Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection
by Bertoletti, Antonio
Gut, 2012, Vol.61 (12), p.1754-1764
114.
HIV transmission rates from persons living with HIV who are aware and unaware of their infection
by HALL, H. Irene
AIDS (London), 2012, Vol.26 (7), p.893-896
115.
Transmission of influenza A in human beings
by Brankston, Gabrielle, MHSc
The Lancet infectious diseases, 2007, Vol.7 (4), p.257-265
116.
Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European mu...
by Wittkop, Linda, Dr
The Lancet infectious diseases, 2011, Vol.11 (5), p.363-371
117.
Infections associated with haemophagocytic syndrome
by Rouphael, Nadine G, Dr
The Lancet infectious diseases, 2007, Vol.7 (12), p.814-822
118.
Dengue
by Halstead, Scott B, Dr
The Lancet (British edition), 2007, Vol.370 (9599), p.1644-1652
119.
Ebola haemorrhagic fever
by Feldmann, Heinz, Dr
The Lancet (British edition), 2011, Vol.377 (9768), p.849-862
